Sultiame once per day in obstructive sleep apnoea (FLOW): a multicentre, randomised, double-blind, placebo-controlled, dose-finding, phase 2 trialWinfried Randerath, Samuel Genzor, Kaj Stenlöf et al.|The Lancet|2025Cited by 15